There were 1,859 press releases posted in the last 24 hours and 399,368 in the last 365 days.

Immunogenicity Case Studies to be Covered at PEGS – the essential protein engineering summit, May 7-9, 2014, Boston

Hear immunogenicity case studies by Amgen, Genentech, Eli Lilly, Biogen Idec, BMS, Celltrion, GlaxoSmithKline, Teva, Shore, ENS-Cachan, and Johns Hopkins.

NEEDHAM, MA, USA, February 27, 2014 /EINPresswire.com/ -- Cambridge Healthtech Institute (CHI) today announced the return of two Immunogenicity conferences that will be a part of the 10th Annual “PEGS – the essential protein & antibody engineering summit” this coming Spring in Boston, MA. PEGS features multiple immunogenicity case studies, speaker presentations and roundtable discussions, to be attended by 1,600+ scientists working in biologics.

6th Annual Immunogenicity for Regulatory Success (May 7-8)
Non-Clinical, Preclinical, and Clinical Strategies for Risk Assessment and Smooth Interaction with the Regulatory Authorities

Topics:
- Assays, Interpretation and Standards
- Immune Complexes and Hypersensitivity
- Immunogenicity Risk Assessment
- Combination Therapy and Complex Mixtures of Drugs


2nd Annual Immunogenicity Prediction and Mitigation (May 8-9)
Risk Factors, Predictive Tools and Immune Tolerance Approaches

Topics:
- Immunogenicity Reduction and Control
- Prediction of Immunogenicity
- Immunogenicity Reduction and Tolerance Induction
- Risk Factors for Immunogenicity
- Pysiological Effects of Protein Aggregation

All the top commercial & academic companies will present on immunogenicity: Amgen, Genentech, Bristol-Myers Squibb, Biogen Idec, GlaxoSmithKline, Lilly, Shire, Teva, ENS-Cachan, Celltrion, Pfizer, Novo Nordisk, Sanofi, Eleven Biotherapeutics, Novartis, Adocia, NIH, Innsbruck Medical University, SUNY-University at Buffalo, and more.

Writers and editors are invited to attend. To request a press pass, contact Lisa Scimemi, lscimemi@healthtech.com.

For more details and to register, visit http://www.pegsummit.com/streams/safety

About Cambridge Healthtech Institute (CHI)
Cambridge Healthtech Institute (CHI), founded in 1992, is the industry leader in providing superior-quality scientific information to eminent researchers and business experts from top pharmaceutical, biotech, and academic organizations. Delivering an assortment of resources such as events, reports, publications and eNewsletters, CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett Educational Services, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, Cambridge Healthtech Media Group, and The Knowledge Foundation. www.chicorporate.com

James Prudhomme
Cambridge Healthtech Institute
781-972-5400
email us here